Cardiorenal end points in a trial of aliskiren for type 2 diabetes
Research output: Contribution to journal › Journal article › Research › peer-review
This study was undertaken to determine whether use of the direct renin inhibitor aliskiren would reduce cardiovascular and renal events in patients with type 2 diabetes and chronic kidney disease, cardiovascular disease, or both.
| Original language | English |
|---|---|
| Journal | New England Journal of Medicine |
| Volume | 367 |
| Issue number | 23 |
| Pages (from-to) | 2204-13 |
| Number of pages | 10 |
| ISSN | 0028-4793 |
| DOIs | |
| Publication status | Published - 2012 |
ID: 48590482